{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:29:23Z","timestamp":1786642163998,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401322"],"award-info":[{"award-number":["81401322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471587"],"award-info":[{"award-number":["81471587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yexcr.2021.112655","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T11:59:08Z","timestamp":1621857548000},"page":"112655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["YAP\/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGF\u03b2 signaling to facilitate PD-L1 expression in M2-like TAMs"],"prefix":"10.1016","volume":"405","author":[{"given":"Xiao-Xiao","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-4029","authenticated-orcid":false,"given":"Lan-Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112655_bib1","series-title":"Clinical Radiation Oncology","first-page":"649","author":"Garden","year":"2016"},{"key":"10.1016\/j.yexcr.2021.112655_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1746-1596-5-35","article-title":"Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx","volume":"5","author":"Sullu","year":"2010","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.yexcr.2021.112655_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112655_bib4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hed.10163","article-title":"Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma","volume":"24","author":"Teknos","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2021.112655_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2021.112655_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2021.112655_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2021.112655_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112655_bib9","article-title":"High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112655_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jso.23881","article-title":"High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer","volume":"111","author":"Sugimura","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.yexcr.2021.112655_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2021.112655_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112655_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2021.112655_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2021.112655_bib15","doi-asserted-by":"crossref","first-page":"P53","DOI":"10.1186\/2051-1426-1-S1-P53","article-title":"Programmed death-ligand 1 (PD-L1) expression in various tumor types","volume":"1","author":"Grosso","year":"2013","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.yexcr.2021.112655_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112655_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.yexcr.2021.112655_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yexcr.2018.10.007","article-title":"YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells","volume":"373","author":"Zhu","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2021.112655_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.117.311950","article-title":"Yes-associated protein promotes angiogenesis via signal transducer and activator of transcription 3 in endothelial cells","volume":"122","author":"He","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2021.112655_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2021.112655_bib21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","article-title":"YAP aggravates inflammatory bowel disease by regulating M1\/M2 macrophage polarization and gut microbial homeostasis","volume":"27","author":"Zhou","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2021.112655_bib22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.31561","article-title":"A time for YAP1: tumorigenesis, immunosuppression and targeted therapy","volume":"143","author":"Shibata","year":"2018","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112655_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.intimp.2014.02.027","article-title":"Dendritic cells with an increased PD-L1 by TGF-\u03b2 induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells","volume":"20","author":"Song","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.yexcr.2021.112655_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3892\/ol.2016.5541","article-title":"Expression and clinical significance of YAP in laryngeal squamous cell carcinoma patients","volume":"13","author":"Qiu","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.yexcr.2021.112655_bib25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/jid.2008.310","article-title":"Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction","volume":"129","author":"Tjiu","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yexcr.2021.112655_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.20082173","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1","volume":"206","author":"Kuang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2021.112655_bib27","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112655_bib28","doi-asserted-by":"crossref","first-page":"E1211","DOI":"10.1073\/pnas.1321347111","article-title":"M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7","volume":"111","author":"Xiao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl 2","key":"10.1016\/j.yexcr.2021.112655_bib29","first-page":"C143","article-title":"Laryngeal cancer incidence and mortality in China, 2010","volume":"11","author":"Zhang","year":"2015","journal-title":"J. Canc. Res. Therapeut."},{"key":"10.1016\/j.yexcr.2021.112655_bib30","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1038\/srep10071","article-title":"Larynx carcinoma regulates tumor-associated macrophages through PLGF signaling","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112655_bib31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.CCR-08-1608","article-title":"Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma","volume":"15","author":"Gao","year":"2009","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2021.112655_bib32","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2021.112655_bib33","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/hep.28710","article-title":"Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features","volume":"64","author":"Calderaro","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2021.112655_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12885-018-4069-3","article-title":"PD-L1 expression in malignant salivary gland tumors","volume":"18","author":"Harada","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2021.112655_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2021.112655_bib36","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-10-0250","article-title":"Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma","volume":"17","author":"Frigola","year":"2011","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2021.112655_bib37","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.18632\/oncotarget.24785","article-title":"Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC)","volume":"9","author":"Vecchiarelli","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2021.112655_bib38","first-page":"104","article-title":"Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications","volume":"26","author":"Zheng","year":"2014","journal-title":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu"},{"key":"10.1016\/j.yexcr.2021.112655_bib39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2326-6066.CIR-16-0329","article-title":"Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade","volume":"5","author":"Zhou","year":"2017","journal-title":"Cancer immunology research"},{"key":"10.1016\/j.yexcr.2021.112655_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12596","article-title":"The prognostic significance of soluble programmed death ligand 1 expression in cancers: a systematic review and meta-analysis","volume":"86","author":"Ding","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.yexcr.2021.112655_bib41","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Gene Dev."},{"key":"10.1016\/j.yexcr.2021.112655_bib42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12885-019-5832-9","article-title":"Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt\/\u03b2-catenin pathway","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2021.112655_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2021.112655_bib44","first-page":"966","article-title":"[Clinical significance of Stat3 and Cyclin D1 expression in laryngeal squamous cell carcinoma]","volume":"25","author":"Wang","year":"2011","journal-title":"Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery"},{"key":"10.1016\/j.yexcr.2021.112655_bib45","article-title":"Aspernolide A inhibits the proliferation of human laryngeal carcinoma cells through the mitochondrial apoptotic and STAT3 signaling pathways","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.yexcr.2021.112655_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3892\/etm.2010.156","article-title":"Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo","volume":"1","author":"Li","year":"2010","journal-title":"Experimental and therapeutic medicine"},{"key":"10.1016\/j.yexcr.2021.112655_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.20101","article-title":"A critical transcription activator in angiogenesis","volume":"28","author":"Chen","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.yexcr.2021.112655_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","article-title":"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112655_bib49","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00277-017-3115-6","article-title":"PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma","volume":"96","author":"Koh","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.yexcr.2021.112655_bib50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jcmm.14027","article-title":"Autocrine VEGF signalling on M2 macrophages regulates PD-L1 expression for immunomodulation of T cells","volume":"23","author":"Lai","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.yexcr.2021.112655_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112655_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08133","article-title":"TGF\u03b2-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance","volume":"5","author":"Baas","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.yexcr.2021.112655_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4049\/jimmunol.192.Supp.61.6","article-title":"TGF-\u03b21 enhances T-cell PD-1 expression through a Smad3-dependant increase in transcription. (IRM4P.499)","volume":"192","author":"Park","year":"2014","journal-title":"J. Immunol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:41:00Z","timestamp":1757997660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0014482721001877"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112655","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YAP\/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGF\u03b2 signaling to facilitate PD-L1 expression in M2-like TAMs","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112655"}}